Profile data is unavailable for this security.
About the company
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
- Revenue in USD (TTM)5.83bn
- Net income in USD708.66m
- Incorporated2016
- Employees17.79k
- LocationSTERIS plc70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
- Phone+353 12322000
- Websitehttps://www.steris.com/
Mergers & acquisitions
| Acquired company | STE:NYQ since announced | Transaction value |
|---|---|---|
| Medik Hospital Design GmbH | -6.73% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Penumbra Inc | 1.33bn | 164.03m | 13.31bn | 4.50k | 81.87 | 9.78 | 73.37 | 9.98 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.40bn | 20.95k | 33.01 | 3.31 | 32.68 | 3.32 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Guardant Health Inc | 902.57m | -398.79m | 13.51bn | 2.00k | -- | -- | -- | 14.97 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.26bn | 15.00k | 44.29 | 1.97 | 21.62 | 3.97 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.75bn | 7.07k | 31.14 | 3.19 | 19.96 | 4.06 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.08bn | 3.90k | 70.43 | 12.34 | 51.17 | 6.77 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Illumina Inc | 4.34bn | 850.00m | 17.86bn | 8.60k | 21.32 | 6.56 | 15.95 | 4.11 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| West Pharmaceutical Services Inc | 3.07bn | 493.70m | 18.04bn | 10.60k | 36.87 | 5.68 | 27.72 | 5.87 | 6.79 | 6.79 | 42.28 | 44.11 | 0.7769 | 4.80 | 5.46 | -- | 12.11 | 15.24 | 14.29 | 18.19 | 35.91 | 37.89 | 15.59 | 18.67 | 2.34 | -- | 0.06 | 9.99 | 6.25 | 7.44 | 0.203 | 7.36 | 10.39 | 5.51 |
| Zimmer Biomet Holdings Inc | 8.23bn | 705.00m | 19.11bn | 17.00k | 27.20 | 1.50 | 10.63 | 2.32 | 3.55 | 3.55 | 41.42 | 64.11 | 0.3703 | 1.10 | 5.17 | -- | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.74 | 0.3718 | 29.10 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
| Steris PLC | 5.83bn | 708.66m | 24.36bn | 17.79k | 34.56 | 3.41 | 20.35 | 4.18 | 7.19 | 7.18 | 59.09 | 72.93 | 0.5658 | 4.92 | 6.12 | 327,662.40 | 6.91 | 5.04 | 7.59 | 5.51 | 44.11 | 43.75 | 12.21 | 10.69 | 1.75 | 20.99 | 0.2094 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.52bn | 720.70m | 26.95bn | 10.30k | 39.59 | 10.02 | 27.92 | 5.97 | 1.77 | 1.77 | 11.08 | 6.99 | 0.6519 | 3.02 | 4.28 | 438,436.90 | 10.40 | 8.79 | 16.41 | 11.75 | 60.20 | 64.97 | 15.96 | 14.90 | 1.38 | -- | 0.4785 | 0.00 | 11.34 | 22.27 | 6.41 | 41.63 | 14.79 | -- |
| Veeva Systems Inc | 3.08bn | 860.33m | 28.62bn | 7.29k | 33.87 | 4.06 | 31.80 | 9.29 | 5.14 | 5.14 | 18.41 | 42.84 | 0.4234 | -- | 9.15 | 422,472.40 | 11.83 | 11.33 | 13.50 | 14.35 | 75.67 | 72.60 | 27.93 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Waters Corp | 3.17bn | 642.63m | 31.72bn | 7.60k | 30.04 | 12.38 | 37.35 | 10.02 | 10.77 | 10.77 | 53.03 | 26.11 | 0.6569 | 2.46 | 4.05 | -- | 13.34 | 17.03 | 14.53 | 20.68 | 59.28 | 59.01 | 20.30 | 22.40 | -- | 16.77 | 0.3546 | -- | 6.99 | 6.00 | 0.7518 | 4.26 | -8.14 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 11.31m | 11.53% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 5.78m | 5.89% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 4.61m | 4.70% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 3.26m | 3.32% |
| Morgan Stanley Investment Management Ltd.as of 31 Dec 2025 | 2.59m | 2.64% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.52m | 2.57% |
| Generation Investment Management LLPas of 31 Dec 2025 | 2.09m | 2.13% |
| Orbis Investment Management Ltd.as of 30 Sep 2025 | 2.04m | 2.08% |
| Select Equity Group LPas of 30 Sep 2025 | 1.98m | 2.01% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 31 Dec 2025 | 1.54m | 1.57% |
